Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised. This report has been conducted by the Office of Health Economics.

The discussions highlighted the crucial role of prevention, treatment and access to immunisation programmes to raise awareness and decrease the cases of RSV hospitalisations and deaths of young children and older adults.

WHO European Region celebrates the European Immunization Week in April to promote awareness of the importance of immunisation in preventing diseases and protecting life.

Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024

How to ensure/prepare for access to immunisation programmes

By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024

Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics

ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.

Keynote Lecture by Dexter Wiseman, Imperial College London

Keynote Lecture by Stefan Gravenstein, Brown University

Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust

COVID-19 vaccines have recently been updated to specifically encode or contain the spike protein of the SARS-CoV-2 XBB.1.5 subvariant.